3136 results for «2763»
3136 results
TAVI unleashed: optimisation of immediate and long-term outcomes
20 Nov 2023 – From PCR London Valves 2023
Consult this session if you want to gain insights into the effects of paravalvular leak, conduction disturbances, stroke, and permanent pacemaker issues following transcatheter aortic valve implantation. The discussion also delves into the design of transcatheter heart valves and its implications for selecting the initial valve...
Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...
19 Nov 2023 – From PCR London Valves 2023
Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND study two-year outcomes: transfemoral TTVR
- Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
- One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
- TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
- Real-world...
Tricuspid transcatheter valve replacement: Cardiovalve keeps things in motion
20 Nov 2023 – From PCR London Valves 2023
Participate in this session to stay informed about the latest advancements in TTVR, receive updates on the Cardiovalve tricuspid program, and gain insights into how imaging demonstrates the concept underlying Cardiovalve transcatheter valve replacement technology.
Essentials of lifetime management of TAVI patients
21 Nov 2023 – From PCR London Valves 2023
Consult this session if you want to learn about the next generation transcatheter heart valve technology key features, procedural and clinical benefits, to learn tips and tricks for managing bicuspid and valve-in-valve interventions, and to understand procedural and clinical relevance of intermediate and XL sizes in...
The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...
19 Nov 2023 – From PCR London Valves 2023
Discover the top late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
- Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
- Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
- Artificial intelligence derived risk...
VitaFlow - The electrically enable self-expanding TAVI valve
21 Nov 2023 – From PCR London Valves 2023
This session provides insights into the unique design and advantages of VitaFlow Liberty for TAVI. It covers techniques to minimize microdislodgement during the procedure, identifies situations and patient types most suitable for VitaFlow Liberty, and reviews early clinical results associated with this technology.
Facing the challenges of resource shortages - An outlook into the future of TAVI?
21 Nov 2023 – From PCR London Valves 2023
Join this session to discover strategies for optimizing care quality and patient safety, especially in resource-constrained environments. Gain insights into variations in TAVI patient treatment across European countries, understanding the associated consequences. Engage in discussions exploring potential solutions to ensure long-term, high-quality patient care despite challenges...
TAVI outcomes - Part 1
19 Nov 2023 – From PCR London Valves 2023
Learn more about TAVI outcomes with this session: examine the impact of high-gradient and discordant low-gradient aortic stenosis, discover the potential of patient-specific computer simulation, explore the critical factor of time to TAVI and its implications in decompensated aortic stenosis cases, dive into the POPular TAVI...
Valve performance and durability - Main considerations in selecting the right TAVI valve
20 Nov 2023 – From PCR London Valves 2023
In this session with LIVE case, participants discuss the critical role of valve selection in influencing patient outcomes. The focus includes understanding the latest clinical outcomes of supra-annular TAVI and SAVR, exploring their practical implications. The session also highlights the contribution of novel technology Evolut FX, in...
TAVI and beyond: tackling coronary challenges
19 Nov 2023 – From PCR London Valves 2023
Consult this session to gain a comprehensive understanding of the crucial role of coronary access post-TAVI, and the impact of TAV design and implantation technique on coronary access. Gain some insights into the intricacies of coronary accessibility from extensive bench test work and the impact of TAV design in...
The catheter-based treatment revolution is just getting started
19 Nov 2023 – From PCR London Valves 2023
Consult this session to stay updated on the latest advancements in transcatheter aortic valve implantations and interventions for tricuspid regurgitation. Gain insights into how recent evidence and innovations are reshaping the treatment landscape for valvular heart disease.
A problem and a solution: aortic regurgitation and the Trilogy TAVI valve
19 Nov 2023 – From PCR London Valves 2023
Consult this session if you want to understand the challenges of imaging for aortic regurgitation and how it can lead to underdiagnosis. Discover the data from the ALIGN-AR trial studying TAVI in aortic regurgitation patients, and learn about the Trilogy valve and the future of TAVI...
Advancements in intracoronary imaging and intervention: unmasking vulnerable plaques and optimising durable PCI outcomes
16 May 2024 – From EuroPCR 2024
Delve into this EuroPCR 2024 session to gain insights into NIRS IVUS, exploring its applications, supported by current data, and understanding its clinical significance. Learn how to utilize NIRS IVUS in PCI planning through case examples, addressing lesion characteristics such as length and calcific nodules. Explore local...
Targeting inflammation in AMI: a debate
14 May 2024 – From EuroPCR 2024
Watch this session to explore inflammation's role in AMI, from atherosclerosis to post-infarct remodeling. Find out more about IL-6's significance in future MACE risk and cardiac status deterioration post-AMI, and delve into targeting inflammation via IL-6, evaluating short and long-term impacts.
Physiology guided post-DCB treatment to safely limit stenting. Validation in complex clinical settings with the optical Optowire III pressure guidewire
16 May 2024 – From EuroPCR 2024
Follow this session to discover how accurate resting index can inform decision-making for DCB in CTO patients and understand the role of physiology in a new PCI workflow for complex MVD. Thus, you will learn about a DCB intention-to-treat strategy guided by post-PCI coronary physiology in...
Advancing percutaneous treatment of pulmonary embolism with computer-assisted vacuum thrombectomy
14 May 2024 – From EuroPCR 2024
Join this session to delve into innovations in computer-assisted vacuum thrombectomy for acute pulmonary embolism, leveraging real-life case scenarios to share practical experiences and discuss treatment strategies. Amidst the current surge in scientific research, ongoing trials like STORM PE and STRIKE PE are pivotal in shaping...
Revisiting thrombus aspiration in STEMI with continuous power aspiration system
15 May 2024 – From EuroPCR 2024
Tune into this 2024 session for insights into the latest ESC guidelines, strategies to prevent and treat no reflow, and an examination of trials like TASTE, TAPAS, and TOTAL on coronary thrombus management. Explore also the outcomes of the CHEETAH study, pondering a potential paradigm shift,...
Ultra-low contrast techniques to improve the safety and quality of PCI in complex and high-risk patients
14 May 2024 – From EuroPCR 2024
Tune in to this session to discover how reducing reliance on contrast opacification enhances procedural safety and enables more thorough revascularization in complex PCI scenarios. Learn that ultra-low contrast (ULC) PCI encompasses various interventional skills and specialized tools, many already familiar to interventional cardiologists. Embrace a...
Go beyond metal: exploring drug-eluting balloon technology in de-novo coronary lesions
15 May 2024 – From EuroPCR 2024
Through the study of two cases, this session examines the need for stenting bifurcation lesions and the role of DEB technology in avoiding stent-related complications in long diffuse disease. It emphasizes the benefits of SELUTION SLR balloons for de novo lesions, discussing how sustained limus release...
Calcified coronary lesions: procedural techniques - Part 1
14 May 2024 – From EuroPCR 2024
This session will feature a series of selected clinical case submissions from EuroPCR 2024, focusing on procedural techniques for the management of calcified coronary lesions. Attendees will have the opportunity to explore various strategies, including the use of angio-based FFR, OCT, rotational atherectomy, and drug-coated balloons,...
